Search Results 1281-1290 of 24401 for Lesion

  1. Mayo Clinic Minute: Cryopreservation giving kids with cancer a brighter future

    Mayo Clinic Q&A: Why are younger people being diagnosed with colorectal cancer? (VIDEO) Robotic-assisted bronchoscopy study of more than 2,000 lung lesions ...

  2. Methoxy polyethylene glycol-epoetin beta (injection route) - Side effects & dosage - Mayo Clinic

    ... lesions, often with a purple center, sore throat, sores, ulcers, or white spots in the mouth of on the lips, or unusual tiredness or weakness. Make sure any ...

  3. A Study for Women who have Platinum Resistant Ovarian Cancer to Evaluate EC145 Combined with Pegylated Liposomal Doxorubicin, Compared to Pegylated Liposomal Doxorubicin Alone - Mayo Clinic

    Must have at least a single (RECIST v1.1-defined) measurable lesion; For the ... lesions, head or neck; Recent (i.e., ≤ 6 weeks) history of abdominal ...

  4. DAYBREAK: Phase 2 Study in Patients With Specific Gene Defects in the MC4R Pathway - Mayo Clinic

    ... lesion), determined as part of a comprehensive skin evaluation performed by the Investigator during Screening. Any concerning lesions identified during ...

  5. Dr. John Pemberton on colon cancer and GI problems - Mayo Clinic News Network

    Mayo Clinic Q&A: Why are younger people being diagnosed with colorectal cancer? (VIDEO) Robotic-assisted bronchoscopy study of more than 2,000 lung lesions ...

  6. Phase IIB/III of TG4010 Immunotherapy in Patients with Stage IV Non-Small Cell Lung Cancer - Mayo Clinic

    At least one measurable lesion by CT scan or MRI based on RECIST version 1.1; PS 0 or 1 on the ECOG scale; Adequate hematological, hepatic, and renal function ...

  7. INCB161734 for Advanced or Metastatic Solid Tumors With KRAS G12D Mutation - Mayo Clinic

    Note: Tumor lesions selected as target lesions should not be selected for biopsy. Ability to swallow and retain oral medication. Willingness to avoid ...

  8. Phase 3 Study to Treat Patients with Soft Tissue Sarcomas - Mayo Clinic

    Measurable tumor lesions according to RECIST 1.1 criteria. ... Evidence of central nervous system (CNS) metastasis who have not received prior definitive therapy ...

  9. A Study of Copanlisib and Nivolumab in Treating Participants With Recurrent or Refractory Diffuse Large B-cell Lymphoma or Primary Mediastinal Large B-cell Lymphoma - Mayo Clinic

    Patients must have measurable disease, defined as at least one lesion that is ≥ 15 mm (≥ 1.5 cm) in the longest axis on cross-sectional imaging and ...

  10. Soft Tissue Tumor Clinical Trials - Mayo Clinic Research

    ... lesion. Expanded Access Program of Ripretinib (DCC-2618) for the Treatment of Patients With Advanced GIST Jacksonville, FL; Rochester, MN; Scottsdale ...